The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluation of patient (Pt), treatment, and prognostic factors in urinary tract adenocarcinoma.
 
Meena Sadaps
No Relationships to Disclose
 
Haris Zahoor
No Relationships to Disclose
 
Paul Elson
No Relationships to Disclose
 
Hamid Emamekhoo
No Relationships to Disclose
 
Kim Schach
No Relationships to Disclose
 
Nicole DiBiase Brey
No Relationships to Disclose
 
Jihad Kaouk
Consulting or Advisory Role - Intuitive Surgical
Speakers' Bureau - Healthtronics
 
Georges-Pascal Haber
Consulting or Advisory Role - Baxter; Intuitive Surgical; Merck
Patents, Royalties, Other Intellectual Property - Cleveland Clinic Innovations
 
Michael C. Gong
No Relationships to Disclose
 
Ryan Kent Berglund
Research Funding - Nucleix (Inst)
 
Venkatesh Krishnamurthi
No Relationships to Disclose
 
James Ulchaker
Consulting or Advisory Role - ForTec Medical
Research Funding - NxThera, Inc (Inst)
 
Timothy D. Gilligan
Travel, Accommodations, Expenses - WellPoint
 
Brian I. Rini
Consulting or Advisory Role - Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Jorge A. Garcia
Consulting or Advisory Role - Bayer; Eisai; Exelixis; Genentech/Roche; Medivation; Pfizer; Sanofi
Speakers' Bureau - Bayer; Genentech/Roche; Medivation/Astellas; Sanofi
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); Lilly (Inst); Orion (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bayer; Eisai; Exelixis; Genentech/Roche; Medivation/Astellas; Pfizer; Sanofi
 
Petros Grivas
Consulting or Advisory Role - Bayer; Dendreon; Genentech
Speakers' Bureau - Genentech
Research Funding - Bayer (Inst); Genentech/Roche (Inst); Genmab (Inst); Merck (Inst); Mirati Therapeutics (Inst); Oncogenex (Inst); Pfizer (Inst)